Back to dashboard
Traditional MedicareReimbursementMedium impact

Newsletter Vol. 19, No. 48

New Jersey Medicaid·NJ·Reimbursement
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

Federal Upper Limits of Payment for Maximum Allowable Cost (MAC) drugs have been revised, affecting reimbursement rates for specific pharmaceutical products. This impacts how much providers will be reimbursed for dispensing or administering certain medications covered under federal programs.

Action Required

Action needed
Immediately: Review Appendix B of Newsletter Vol. 19, No. 48 to identify specific MAC drugs with revised payment limits. Update billing system with new reimbursement rates for affected pharmaceutical products. Verify current inventory pricing against new MAC limits to avoid potential losses on drug dispensing.

Related policy hubs